News
Fosfomicin JGL in JGL’s prescription portfolio
At the end of 2017, JGL enriched its prescription portfolio with a new product.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.